Proteos
Proteos Leadership Team
George B. Gross
President and CEO
Mr. Gross was named President of Proteos in 2010. Previously, he served as Vice President of Business Development for 6 years, directing sales and business development activities for Proteos. He brought over 30 years of sales and marketing leadership from Upjohn/Pharmacia to the management team of Proteos. Mr. Gross is a graduate of Texas Tech University.
Martin R. Deibel, Jr., Ph.D.
Chief Scientific Officer
Dr. Deibel received his Ph.D. in Biochemistry from the Ohio State University, followed by a postdoctoral fellowship and research assistant professorship at the University of Kentucky in the Department of Biochemistry. His industrial experience includes 19 years at Upjohn/Pharmacia in Kalamazoo in leading team efforts in production, purification, and assay development of key target proteins in a number of therapeutic areas. His recent experience includes 7 years as Head of Protein Purification at Proteos, Inc. Dr. Deibel lists over 75 peer reviewed papers in protein science.
Holly Kehoe
Controller
Mrs. Kehoe manages Proteos' finances. She brings 18 years of accounting experience working with small businesses. Mrs. Kehoe is a graduate of Western Michigan University.
Lindsey Gottler, Ph.D.
Lead Scientist, Biochemistry
Dr. Gottler received her Ph.D in chemistry at the University of Michigan. She then completed a post doctoral fellowship at the University of Michigan in biophysical chemistry. Her research experience includes protein design and engineering of recombinant and synthetically produced proteins and peptides, protein purification, chemical modification of biomolecules, and biophysical analysis of proteins and peptides.
Jason Haineault
Lead Scientist, Cell Biology
Mr. Haineault received his Master’s degree in Biology from the University of Nebraska where he studied production of antimicrobial peptides. Mr. Haineault joined Proteos in 2006. His research experience includes cellular expression systems and protein purification methods used for the production of recombinant proteins. Mr. Haineault specializes in the expression of recombinant proteins in mammalian, insect and bacterial expression systems.
Mary Shuck
Lead Scientist, Cell Biology
Ms. Shuck spent 25 years as a Discovery Research Scientist in the pharmaceutical industry prior to joining Proteos in 2009. Her work focused on the identification and in vitro pharmacology of a broad range of drug targets, including: receptors, ion channels, transporters, enzymes and second messengers. She has expertise in all aspects of cell and molecular biology, with focus on reagent provision and cell-based assay development designed to facilitate lead identification and define mechanism of action. She is a graduate of Bethel College in McKenzie, TN.
Founders
Robert L. Heinrikson, Ph.D.
Co-Founder & Chief Scientific Advisor
Dr. Heinrikson is known internationally as one of the world's leading protein chemists. His career has been equally divided between academia and the pharmaceutical industry, with 18 years as Professor of Biochemistry at the University of Chicago and 19 years as Senior Research Scientist and Distinguished Fellow at Upjohn/Pharmacia in Kalamazoo, MI. He is on the editorial board of four journals in the field of biochemistry, with 20 years service as editor of the Journal of Biological Chemistry. Dr. Heinrikson's field of expertise is protein chemistry and protein structure-function relationships; he lists >200 peer-reviewed publications, review articles and book chapters.
Clark W. Smith, Ph.D.
Co-Founder, Chairman of the Board
Dr. Smith's career spans 6 years in academia and 23 years at Upjohn/Pharmacia in Kalamazoo where he was Director of Protein Sciences and leader of the peptide synthesis group. From 1998-2003, Dr. Smith was Senior Director of Global Research Site Operations. His expertise is in peptide chemistry, and he is one of the founding officers of the American Peptide Society with >85 peer-reviewed publications.